Business Description
Poxel SA
ISIN : FR0012432516
Compare
Compare
Traded in other countries / regions
POXEL.France0RA2.UK7PO.GermanyPXXLF.USA IPO Date
2015-02-05Description
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.
Financial Strength
1/10
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.3 | |||||
9-Day RSI | 51.52 | |||||
14-Day RSI | 55.12 | |||||
6-1 Month Momentum % | 41.24 | |||||
12-1 Month Momentum % | -26.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -3239.76 |
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Poxel SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.674 | ||
EPS (TTM) (€) | -1.08 | ||
Beta | 1.4 | ||
Volatility % | 72.31 | ||
14-Day RSI | 55.12 | ||
14-Day ATR (€) | 0.076382 | ||
20-Day SMA (€) | 0.65875 | ||
12-1 Month Momentum % | -26.25 | ||
52-Week Range (€) | 0.297 - 0.95 | ||
Shares Outstanding (Mil) | 38.6 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Poxel SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Poxel SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Poxel SA Frequently Asked Questions
What is Poxel SA(XPAR:POXEL)'s stock price today?
The current price of XPAR:POXEL is €0.67. The 52 week high of XPAR:POXEL is €0.95 and 52 week low is €0.30.
When is next earnings date of Poxel SA(XPAR:POXEL)?
The next earnings date of Poxel SA(XPAR:POXEL) is 2024-05-16.
Does Poxel SA(XPAR:POXEL) pay dividends? If so, how much?
Poxel SA(XPAR:POXEL) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |